Monthly information on share capital and company voting rights
Cellectis has released its monthly share capital and voting rights information as of November 30, 2024. The company reported a total of 100,093,873 shares in the capital and 88,576,206 voting rights. This disclosure is made in accordance with Article 223-16 of the General Regulation of the French financial markets authority, with the company's shares listed on Euronext Growth under ISIN code FR0010425595.
Cellectis ha pubblicato le informazioni mensili riguardanti il capitale sociale e i diritti di voto al 30 novembre 2024. L'azienda ha riportato un totale di 100.093.873 azioni nel capitale e 88.576.206 diritti di voto. Questa divulgazione è effettuata ai sensi dell'Articolo 223-16 del Regolamento Generale dell'autorità dei mercati finanziari francesi, con le azioni dell'azienda quotate su Euronext Growth con codice ISIN FR0010425595.
Cellectis ha publicado su información mensual sobre el capital social y los derechos de voto a partir del 30 de noviembre de 2024. La compañía reportó un total de 100.093.873 acciones en el capital y 88.576.206 derechos de voto. Esta divulgación se realiza de acuerdo con el Artículo 223-16 del Reglamento General de la autoridad de los mercados financieros franceses, con las acciones de la compañía cotizadas en Euronext Growth bajo el código ISIN FR0010425595.
Cellectis는 2024년 11월 30일 기준의 월간 자본금 및 의결권 정보를 발표했습니다. 회사는 총 100,093,873 주식과 88,576,206 의결권을 보고했습니다. 이 공시는 프랑스 금융 시장 당국의 일반 규정 제223-16조에 따라 이루어지며, 회사의 주식은 Euronext Growth에 ISIN 코드 FR0010425595로 상장되어 있습니다.
Cellectis a publié ses informations mensuelles sur le capital social et les droits de vote au 30 novembre 2024. La société a rapporté un total de 100 093 873 actions dans le capital et 88 576 206 droits de vote. Cette divulgation est effectuée conformément à l'article 223-16 du règlement général de l'autorité des marchés financiers français, avec les actions de l'entreprise cotées sur Euronext Growth sous le code ISIN FR0010425595.
Cellectis hat die monatlichen Informationen zu seinem Grundkapital und den Stimmrechten zum 30. November 2024 veröffentlicht. Das Unternehmen berichtete über insgesamt 100.093.873 Aktien im Kapital und 88.576.206 Stimmrechte. Diese Offenlegung erfolgt gemäß Artikel 223-16 der allgemeinen Vorschriften der französischen Finanzmarktbehörde, mit den Aktien des Unternehmens, die an der Euronext Growth unter der ISIN-Nummer FR0010425595 notiert sind.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 11/30/2024 | 100,093,873 | 88,576,206 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
FAQ
How many shares does Cellectis (CLLS) have as of November 30, 2024?
What is the total number of voting rights for Cellectis (CLLS) as of November 2024?
On which exchange are Cellectis (CLLS) shares listed?
